documents: FDA-2023-N-0061-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-0061-0001 FDA FDA-2023-N-0061 Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act Proposed Rule Notice of Proposed Rulemaking (NPRM) 2024-03-20T04:00:00Z 2024 3 2024-03-20T04:00:00Z 2024-06-19T03:59:59Z 2024-06-20T01:00:32Z 2024-05801 0 0 090000648648745b

Links from other tables